View Future GrowthSoken Chemical & Engineering 過去の業績過去 基準チェック /36Soken Chemical & Engineeringは、平均年間17.3%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.1% 6.8%収益成長率で 成長しています。 Soken Chemical & Engineeringの自己資本利益率は10.6%であり、純利益率は9.1%です。主要情報17.27%収益成長率17.10%EPS成長率Chemicals 業界の成長6.58%収益成長率6.81%株主資本利益率10.58%ネット・マージン9.10%次回の業績アップデート05 Nov 2026最近の業績更新Reported Earnings • Aug 06First quarter 2027 earnings released: EPS: JP¥83.04 (vs JP¥57.78 in 1Q 2026)First quarter 2027 results: EPS: JP¥83.04 (up from JP¥57.78 in 1Q 2026). Revenue: JP¥12.5b (up 9.7% from 1Q 2026). Net income: JP¥1.38b (up 44% from 1Q 2026). Profit margin: 11% (up from 8.4% in 1Q 2026). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 09+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q2, 2027 Results on Nov 05, 2026Soken Chemical & Engineering Co., Ltd. announced that they will report Q2, 2027 results on Nov 05, 2026Reported Earnings • Feb 17Third quarter 2026 earnings released: EPS: JP¥74.11 (vs JP¥69.48 in 3Q 2025)Third quarter 2026 results: EPS: JP¥74.11 (up from JP¥69.48 in 3Q 2025). Revenue: JP¥12.1b (up 12% from 3Q 2025). Net income: JP¥1.23b (up 6.8% from 3Q 2025). Profit margin: 10% (in line with 3Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Nov 07Second quarter 2026 earnings released: EPS: JP¥68.30 (vs JP¥81.40 in 2Q 2025)Second quarter 2026 results: EPS: JP¥68.30 (down from JP¥81.40 in 2Q 2025). Revenue: JP¥11.4b (down 10% from 2Q 2025). Net income: JP¥1.13b (down 16% from 2Q 2025). Profit margin: 10.0% (in line with 2Q 2025). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year whereas the company’s share price has increased by 39% per year.Reported Earnings • Aug 07First quarter 2026 earnings released: EPS: JP¥57.78 (vs JP¥87.85 in 1Q 2025)First quarter 2026 results: EPS: JP¥57.78 (down from JP¥87.85 in 1Q 2025). Revenue: JP¥11.4b (down 2.4% from 1Q 2025). Net income: JP¥958.0m (down 34% from 1Q 2025). Profit margin: 8.4% (down from 13% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 20Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: JP¥528 (up from JP¥159 in FY 2024). Revenue: JP¥47.6b (up 15% from FY 2024). Net income: JP¥4.38b (up 67% from FY 2024). Profit margin: 9.2% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesReported Earnings • Aug 06First quarter 2027 earnings released: EPS: JP¥83.04 (vs JP¥57.78 in 1Q 2026)First quarter 2027 results: EPS: JP¥83.04 (up from JP¥57.78 in 1Q 2026). Revenue: JP¥12.5b (up 9.7% from 1Q 2026). Net income: JP¥1.38b (up 44% from 1Q 2026). Profit margin: 11% (up from 8.4% in 1Q 2026). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥3,035, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in Japan. Total returns to shareholders of 246% over the past three years.New Risk • Jul 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.7% average weekly change).New Risk • May 20New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.6% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.お知らせ • May 15Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2026Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2026.お知らせ • May 09+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q2, 2027 Results on Nov 05, 2026Soken Chemical & Engineering Co., Ltd. announced that they will report Q2, 2027 results on Nov 05, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥75.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 26 June 2026. Payout ratio is a comfortable 28% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.3%).Reported Earnings • Feb 17Third quarter 2026 earnings released: EPS: JP¥74.11 (vs JP¥69.48 in 3Q 2025)Third quarter 2026 results: EPS: JP¥74.11 (up from JP¥69.48 in 3Q 2025). Revenue: JP¥12.1b (up 12% from 3Q 2025). Net income: JP¥1.23b (up 6.8% from 3Q 2025). Profit margin: 10% (in line with 3Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Nov 07Second quarter 2026 earnings released: EPS: JP¥68.30 (vs JP¥81.40 in 2Q 2025)Second quarter 2026 results: EPS: JP¥68.30 (down from JP¥81.40 in 2Q 2025). Revenue: JP¥11.4b (down 10% from 2Q 2025). Net income: JP¥1.13b (down 16% from 2Q 2025). Profit margin: 10.0% (in line with 2Q 2025). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year whereas the company’s share price has increased by 39% per year.Reported Earnings • Aug 07First quarter 2026 earnings released: EPS: JP¥57.78 (vs JP¥87.85 in 1Q 2025)First quarter 2026 results: EPS: JP¥57.78 (down from JP¥87.85 in 1Q 2025). Revenue: JP¥11.4b (down 2.4% from 1Q 2025). Net income: JP¥958.0m (down 34% from 1Q 2025). Profit margin: 8.4% (down from 13% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Jul 30Now 20% undervaluedOver the last 90 days, the stock has risen 12% to JP¥1,675. The fair value is estimated to be JP¥2,098, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.7% over the last 3 years. Earnings per share has grown by 36%. Revenue is forecast to grow by 11% in 2 years. Earnings are forecast to grow by 30% in the next 2 years.Reported Earnings • May 20Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: JP¥528 (up from JP¥159 in FY 2024). Revenue: JP¥47.6b (up 15% from FY 2024). Net income: JP¥4.38b (up 67% from FY 2024). Profit margin: 9.2% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.お知らせ • May 15Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 25, 2025Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 25, 2025.Upcoming Dividend • Mar 21Upcoming dividend of JP¥125 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 27 June 2025. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).お知らせ • Feb 28+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q1, 2026 Results on Aug 05, 2025Soken Chemical & Engineering Co., Ltd. announced that they will report Q1, 2026 results on Aug 05, 2025New Risk • Feb 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.2% average weekly change).Reported Earnings • Feb 06Third quarter 2025 earnings released: EPS: JP¥139 (vs JP¥119 in 3Q 2024)Third quarter 2025 results: EPS: JP¥139 (up from JP¥119 in 3Q 2024). Revenue: JP¥10.9b (down 7.5% from 3Q 2024). Net income: JP¥1.15b (up 17% from 3Q 2024). Profit margin: 11% (up from 8.4% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 28% per year whereas the company’s share price has increased by 24% per year.分析記事 • Dec 11Soken Chemical & Engineering (TSE:4972) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Reported Earnings • Nov 08Second quarter 2025 earnings released: EPS: JP¥163 (vs JP¥99.81 in 2Q 2024)Second quarter 2025 results: EPS: JP¥163 (up from JP¥99.81 in 2Q 2024). Revenue: JP¥12.7b (up 24% from 2Q 2024). Net income: JP¥1.35b (up 63% from 2Q 2024). Profit margin: 11% (up from 8.1% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 20% per year.Board Change • Nov 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Outside Director Takayoshi Fusegi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.3% average weekly change).Buy Or Sell Opportunity • Sep 17Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to JP¥3,230. The fair value is estimated to be JP¥2,669, however this is not to be taken as a sell recommendation but rather should be used as a guide only.分析記事 • Sep 01Soken Chemical & Engineering Co., Ltd. (TSE:4972) Soars 29% But It's A Story Of Risk Vs RewardSoken Chemical & Engineering Co., Ltd. ( TSE:4972 ) shares have had a really impressive month, gaining 29% after a...Reported Earnings • Aug 07First quarter 2025 earnings released: EPS: JP¥176 (vs JP¥66.30 in 1Q 2024)First quarter 2025 results: EPS: JP¥176 (up from JP¥66.30 in 1Q 2024). Revenue: JP¥11.7b (up 29% from 1Q 2024). Net income: JP¥1.46b (up 166% from 1Q 2024). Profit margin: 13% (up from 6.1% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 7% per year, which means it is tracking significantly ahead of earnings growth.Buy Or Sell Opportunity • Aug 06Now 22% overvaluedOver the last 90 days, the stock has fallen 13% to JP¥2,600. The fair value is estimated to be JP¥2,136, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has declined by 12%. For the next 3 years, revenue is forecast to grow by 8.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.9% average weekly change).Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to JP¥2,100, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 13% over the past three years.Reported Earnings • May 21Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: JP¥318 (up from JP¥174 in FY 2023). Revenue: JP¥41.3b (up 8.4% from FY 2023). Net income: JP¥2.63b (up 83% from FY 2023). Profit margin: 6.4% (up from 3.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 6.0%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.お知らせ • May 17Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 26, 2024Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 26, 2024.New Risk • Apr 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.7% average weekly change).Upcoming Dividend • Mar 21Upcoming dividend of JP¥95.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 26 June 2024. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).お知らせ • Mar 02+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q1, 2025 Results on Aug 05, 2024Soken Chemical & Engineering Co., Ltd. announced that they will report Q1, 2025 results on Aug 05, 2024Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: JP¥119 (vs JP¥7.50 in 3Q 2023)Third quarter 2024 results: EPS: JP¥119 (up from JP¥7.50 in 3Q 2023). Revenue: JP¥11.8b (up 22% from 3Q 2023). Net income: JP¥988.0m (up JP¥926.0m from 3Q 2023). Profit margin: 8.4% (up from 0.6% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • Jan 24Now 20% undervaluedOver the last 90 days, the stock has risen 46% to JP¥2,688. The fair value is estimated to be JP¥3,368, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has declined by 21%. Revenue is forecast to grow by 29% in 2 years. Earnings are forecast to grow by 91% in the next 2 years.New Risk • Nov 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.4% average weekly change).Reported Earnings • Nov 07Second quarter 2024 earnings released: EPS: JP¥99.80 (vs JP¥29.54 in 2Q 2023)Second quarter 2024 results: EPS: JP¥99.80 (up from JP¥29.54 in 2Q 2023). Revenue: JP¥10.2b (up 12% from 2Q 2023). Net income: JP¥826.0m (up 238% from 2Q 2023). Profit margin: 8.1% (up from 2.7% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥2,105, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 70% over the past three years.New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.4b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.1% net profit margin). Market cap is less than US$100m (JP¥14.4b market cap, or US$99.1m).New Risk • Aug 09New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 5.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.1% net profit margin).Reported Earnings • Aug 09First quarter 2024 earnings released: EPS: JP¥66.29 (vs JP¥101 in 1Q 2023)First quarter 2024 results: EPS: JP¥66.29 (down from JP¥101 in 1Q 2023). Revenue: JP¥9.05b (down 13% from 1Q 2023). Net income: JP¥548.0m (down 34% from 1Q 2023). Profit margin: 6.1% (down from 8.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Reported Earnings • May 19Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: JP¥174 (down from JP¥247 in FY 2022). Revenue: JP¥38.1b (down 1.3% from FY 2022). Net income: JP¥1.44b (down 30% from FY 2022). Profit margin: 3.8% (down from 5.3% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 11%. Revenue is forecast to grow 9.4% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Upcoming Dividend • Mar 23Upcoming dividend of JP¥85.00 per share at 4.8% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 27 June 2023. Payout ratio is a comfortable 41% but the company is not cash flow positive. Trailing yield: 4.8%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).Reported Earnings • Feb 04Third quarter 2023 earnings released: EPS: JP¥7.50 (vs JP¥61.32 in 3Q 2022)Third quarter 2023 results: EPS: JP¥7.50 (down from JP¥61.32 in 3Q 2022). Revenue: JP¥9.64b (down 4.8% from 3Q 2022). Net income: JP¥62.0m (down 88% from 3Q 2022). Profit margin: 0.6% (down from 5.0% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 9% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Nov 16No independent directorsThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 8 new directors. 3 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). President & Director Junichiro Fukuda is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Nov 06Second quarter 2023 earnings released: EPS: JP¥29.54 (vs JP¥59.67 in 2Q 2022)Second quarter 2023 results: EPS: JP¥29.54 (down from JP¥59.67 in 2Q 2022). Revenue: JP¥9.08b (flat on 2Q 2022). Net income: JP¥244.0m (down 50% from 2Q 2022). Profit margin: 2.7% (down from 5.5% in 2Q 2022). Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 13% per year.Reported Earnings • Aug 07First quarter 2023 earnings released: EPS: JP¥101 (vs JP¥83.42 in 1Q 2022)First quarter 2023 results: EPS: JP¥101 (up from JP¥83.42 in 1Q 2022). Revenue: JP¥10.4b (up 19% from 1Q 2022). Net income: JP¥836.0m (up 22% from 1Q 2022). Profit margin: 8.1% (up from 7.9% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.0%, compared to a 9.5% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 17Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: JP¥247 (down from JP¥331 in FY 2021). Revenue: JP¥38.6b (up 23% from FY 2021). Net income: JP¥2.04b (down 25% from FY 2021). Profit margin: 5.3% (down from 8.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 36%. Over the next year, revenue is forecast to stay flat compared to a 7.7% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.お知らせ • May 15Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2022Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2022.Board Change • Apr 27No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 8 non-independent directors. Full-Time Auditor Nobuyuki Izumiura was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.お知らせ • Apr 08+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q2, 2023 Results on Nov 04, 2022Soken Chemical & Engineering Co., Ltd. announced that they will report Q2, 2023 results on Nov 04, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥75.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (2.6%).Reported Earnings • Feb 07Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: JP¥61.31 (down from JP¥104 in 3Q 2021). Revenue: JP¥10.1b (up 21% from 3Q 2021). Net income: JP¥506.0m (down 41% from 3Q 2021). Profit margin: 5.0% (down from 10% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) also surpassed analyst estimates by 13%. Over the next year, revenue is forecast to grow 4.2%, compared to a 6.8% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 07Second quarter 2022 earnings released: EPS JP¥59.66 (vs JP¥83.13 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: JP¥9.02b (up 25% from 2Q 2021). Net income: JP¥492.0m (down 28% from 2Q 2021). Profit margin: 5.5% (down from 9.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 07Second quarter 2022 earnings released: EPS JP¥59.66 (vs JP¥83.13 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: JP¥9.02b (up 25% from 2Q 2021). Net income: JP¥492.0m (down 28% from 2Q 2021). Profit margin: 5.5% (down from 9.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 29Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥1,770, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 11x in the Chemicals industry in Japan. Total returns to shareholders of 14% over the past three years.Reported Earnings • Aug 05First quarter 2022 earnings released: EPS JP¥83.41 (vs JP¥61.83 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥8.72b (up 28% from 1Q 2021). Net income: JP¥687.0m (up 35% from 1Q 2021). Profit margin: 7.9% (up from 7.5% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 17Full year 2021 earnings released: EPS JP¥331 (vs JP¥198 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥31.5b (up 9.7% from FY 2020). Net income: JP¥2.72b (up 67% from FY 2020). Profit margin: 8.6% (up from 5.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.分析記事 • May 02Soken Chemical & Engineering (TYO:4972) Is Doing The Right Things To Multiply Its Share PriceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Upcoming Dividend • Mar 23Upcoming dividend of JP¥75.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 26 June 2021. Trailing yield: 3.3%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.8%).分析記事 • Mar 11These 4 Measures Indicate That Soken Chemical & Engineering (TYO:4972) Is Using Debt SafelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Feb 21Should You Think About Buying Soken Chemical & Engineering Co., Ltd. (TYO:4972) Now?While Soken Chemical & Engineering Co., Ltd. ( TYO:4972 ) might not be the most widely known stock at the moment, it...Is New 90 Day High Low • Feb 08New 90-day high: JP¥2,545The company is up 55% from its price of JP¥1,643 on 10 November 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.Reported Earnings • Feb 07Third quarter 2021 earnings released: EPS JP¥104 (vs JP¥71.81 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥8.38b (up 17% from 3Q 2020). Net income: JP¥860.0m (up 46% from 3Q 2020). Profit margin: 10% (up from 8.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Analyst Estimate Surprise Post Earnings • Feb 07Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 2.8%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Over the next year, revenue is forecast to grow 5.3%, compared to a 6.2% growth forecast for the Chemicals industry in Japan.分析記事 • Feb 02Why Dividend Hunters Love Soken Chemical & Engineering Co., Ltd. (TYO:4972)Dividend paying stocks like Soken Chemical & Engineering Co., Ltd. ( TYO:4972 ) tend to be popular with investors, and...分析記事 • Jan 15What Do The Returns At Soken Chemical & Engineering (TYO:4972) Mean Going Forward?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Is New 90 Day High Low • Jan 13New 90-day high: JP¥2,120The company is up 39% from its price of JP¥1,526 on 15 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period.Is New 90 Day High Low • Dec 29New 90-day high: JP¥1,931The company is up 29% from its price of JP¥1,499 on 30 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.分析記事 • Dec 28Did You Participate In Any Of Soken Chemical & Engineering's (TYO:4972) Fantastic 117% Return ?Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...分析記事 • Dec 10We Think Soken Chemical & Engineering (TYO:4972) Can Manage Its Debt With EaseThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Is New 90 Day High Low • Dec 08New 90-day high: JP¥1,919The company is up 39% from its price of JP¥1,383 on 09 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.分析記事 • Nov 22Is Soken Chemical & Engineering Co., Ltd. (TYO:4972) Potentially Undervalued?While Soken Chemical & Engineering Co., Ltd. (TYO:4972) might not be the most widely known stock at the moment, it saw...Reported Earnings • Nov 07Second quarter 2021 earnings released: EPS JP¥83.13The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: JP¥7.21b (down 1.2% from 2Q 2020). Net income: JP¥684.0m (up 50% from 2Q 2020). Profit margin: 9.5% (up from 6.2% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 8% per year.Analyst Estimate Surprise Post Earnings • Nov 07Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Over the next year, revenue is forecast to stay flat compared to a 2.0% growth forecast for the Chemicals industry in Japan.Is New 90 Day High Low • Nov 06New 90-day high: JP¥1,770The company is up 38% from its price of JP¥1,286 on 07 August 2020. The Japanese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Nov 06Market bids up stock over the past weekAfter last week's 26% share price gain to JP¥1,770, the stock is trading at a trailing P/E ratio of 7.7x, up from the previous P/E ratio of 6.1x. This compares to an average P/E of 14x in the Chemicals industry in Japan. Total return to shareholders over the past three years is a loss of 11%.Is New 90 Day High Low • Oct 05New 90-day high: JP¥1,516The company is up 25% from its price of JP¥1,209 on 07 July 2020. The Japanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.収支内訳Soken Chemical & Engineering の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TSE:4972 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費30 Jun 2649,0714,4668,7241,46531 Mar 2647,9674,0468,4761,46531 Dec 2547,3003,7438,5241,30230 Sep 2546,0533,6658,1941,30230 Jun 2547,3553,8818,2401,30231 Mar 2547,6334,3788,1281,30231 Dec 2445,5104,2237,5281,33530 Sep 2446,3944,0597,7191,33530 Jun 2443,9293,5367,5121,33531 Mar 2441,3182,6297,3911,33531 Dec 2340,0492,6567,1071,40430 Sep 2337,9291,7306,7661,40430 Jun 2336,8041,1486,7131,40431 Mar 2338,1291,4366,7391,40431 Dec 2239,8681,4977,0711,45530 Sep 2240,3501,9417,0331,45530 Jun 2240,2912,1896,8251,45531 Mar 2238,6382,0406,5901,45531 Dec 2136,9702,3576,3881,42130 Sep 2135,2312,7116,3001,42130 Jun 2133,4142,9036,0911,42131 Mar 2131,4932,7245,8691,42131 Dec 2029,9132,3895,6771,46830 Sep 2028,6702,1195,4421,46830 Jun 2028,7601,8915,4311,46831 Mar 2028,6991,6355,5921,46831 Dec 1928,5091,4775,3631,52230 Sep 1929,7231,3595,4421,52230 Jun 1930,6301,2755,5631,52231 Mar 1931,2951,4625,4451,52231 Dec 1832,0351,4625,5811,59930 Sep 1832,0511,8395,5851,59930 Jun 1831,1281,9835,6391,59931 Mar 1830,0501,9645,6191,59931 Dec 1729,2962,0965,4811,69030 Sep 1727,4921,7495,3741,69030 Jun 1726,4661,5265,1161,69031 Mar 1726,1391,3425,1471,69031 Dec 1625,1931,0204,7231,95330 Sep 1625,3378204,7481,95330 Jun 1625,8806295,0181,95331 Mar 1626,0195295,1241,95331 Dec 1527,7496055,1872,11530 Sep 1528,9195965,3022,115質の高い収益: 4972は 高品質の収益 を持っています。利益率の向上: 4972の現在の純利益率 (9.1%)は、昨年(8.2%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 4972の収益は過去 5 年間で年間17.3%増加しました。成長の加速: 4972の過去 1 年間の収益成長率 ( 15.1% ) は、5 年間の平均 ( 年間17.3%を下回っています。収益対業界: 4972の過去 1 年間の収益成長率 ( 15.1% ) Chemicals業界24.6%を上回りませんでした。株主資本利益率高いROE: 4972の 自己資本利益率 ( 10.6% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/20 12:01終値2026/08/20 00:00収益2026/06/30年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Soken Chemical & Engineering Co., Ltd. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Tokushi YamasakiDaiwa Securities Co. Ltd.Katsuhiko IshibashiIchiyoshi Research Institute Inc.Kazuto TakamiMizuho Securities Co., Ltd.
Reported Earnings • Aug 06First quarter 2027 earnings released: EPS: JP¥83.04 (vs JP¥57.78 in 1Q 2026)First quarter 2027 results: EPS: JP¥83.04 (up from JP¥57.78 in 1Q 2026). Revenue: JP¥12.5b (up 9.7% from 1Q 2026). Net income: JP¥1.38b (up 44% from 1Q 2026). Profit margin: 11% (up from 8.4% in 1Q 2026). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 09+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q2, 2027 Results on Nov 05, 2026Soken Chemical & Engineering Co., Ltd. announced that they will report Q2, 2027 results on Nov 05, 2026
Reported Earnings • Feb 17Third quarter 2026 earnings released: EPS: JP¥74.11 (vs JP¥69.48 in 3Q 2025)Third quarter 2026 results: EPS: JP¥74.11 (up from JP¥69.48 in 3Q 2025). Revenue: JP¥12.1b (up 12% from 3Q 2025). Net income: JP¥1.23b (up 6.8% from 3Q 2025). Profit margin: 10% (in line with 3Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Nov 07Second quarter 2026 earnings released: EPS: JP¥68.30 (vs JP¥81.40 in 2Q 2025)Second quarter 2026 results: EPS: JP¥68.30 (down from JP¥81.40 in 2Q 2025). Revenue: JP¥11.4b (down 10% from 2Q 2025). Net income: JP¥1.13b (down 16% from 2Q 2025). Profit margin: 10.0% (in line with 2Q 2025). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year whereas the company’s share price has increased by 39% per year.
Reported Earnings • Aug 07First quarter 2026 earnings released: EPS: JP¥57.78 (vs JP¥87.85 in 1Q 2025)First quarter 2026 results: EPS: JP¥57.78 (down from JP¥87.85 in 1Q 2025). Revenue: JP¥11.4b (down 2.4% from 1Q 2025). Net income: JP¥958.0m (down 34% from 1Q 2025). Profit margin: 8.4% (down from 13% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 20Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: JP¥528 (up from JP¥159 in FY 2024). Revenue: JP¥47.6b (up 15% from FY 2024). Net income: JP¥4.38b (up 67% from FY 2024). Profit margin: 9.2% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 06First quarter 2027 earnings released: EPS: JP¥83.04 (vs JP¥57.78 in 1Q 2026)First quarter 2027 results: EPS: JP¥83.04 (up from JP¥57.78 in 1Q 2026). Revenue: JP¥12.5b (up 9.7% from 1Q 2026). Net income: JP¥1.38b (up 44% from 1Q 2026). Profit margin: 11% (up from 8.4% in 1Q 2026). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥3,035, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in Japan. Total returns to shareholders of 246% over the past three years.
New Risk • Jul 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.7% average weekly change).
New Risk • May 20New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.6% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
お知らせ • May 15Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2026Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2026.
お知らせ • May 09+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q2, 2027 Results on Nov 05, 2026Soken Chemical & Engineering Co., Ltd. announced that they will report Q2, 2027 results on Nov 05, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥75.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 26 June 2026. Payout ratio is a comfortable 28% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.3%).
Reported Earnings • Feb 17Third quarter 2026 earnings released: EPS: JP¥74.11 (vs JP¥69.48 in 3Q 2025)Third quarter 2026 results: EPS: JP¥74.11 (up from JP¥69.48 in 3Q 2025). Revenue: JP¥12.1b (up 12% from 3Q 2025). Net income: JP¥1.23b (up 6.8% from 3Q 2025). Profit margin: 10% (in line with 3Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Nov 07Second quarter 2026 earnings released: EPS: JP¥68.30 (vs JP¥81.40 in 2Q 2025)Second quarter 2026 results: EPS: JP¥68.30 (down from JP¥81.40 in 2Q 2025). Revenue: JP¥11.4b (down 10% from 2Q 2025). Net income: JP¥1.13b (down 16% from 2Q 2025). Profit margin: 10.0% (in line with 2Q 2025). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year whereas the company’s share price has increased by 39% per year.
Reported Earnings • Aug 07First quarter 2026 earnings released: EPS: JP¥57.78 (vs JP¥87.85 in 1Q 2025)First quarter 2026 results: EPS: JP¥57.78 (down from JP¥87.85 in 1Q 2025). Revenue: JP¥11.4b (down 2.4% from 1Q 2025). Net income: JP¥958.0m (down 34% from 1Q 2025). Profit margin: 8.4% (down from 13% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Jul 30Now 20% undervaluedOver the last 90 days, the stock has risen 12% to JP¥1,675. The fair value is estimated to be JP¥2,098, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.7% over the last 3 years. Earnings per share has grown by 36%. Revenue is forecast to grow by 11% in 2 years. Earnings are forecast to grow by 30% in the next 2 years.
Reported Earnings • May 20Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: JP¥528 (up from JP¥159 in FY 2024). Revenue: JP¥47.6b (up 15% from FY 2024). Net income: JP¥4.38b (up 67% from FY 2024). Profit margin: 9.2% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
お知らせ • May 15Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 25, 2025Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 25, 2025.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥125 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 27 June 2025. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).
お知らせ • Feb 28+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q1, 2026 Results on Aug 05, 2025Soken Chemical & Engineering Co., Ltd. announced that they will report Q1, 2026 results on Aug 05, 2025
New Risk • Feb 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.2% average weekly change).
Reported Earnings • Feb 06Third quarter 2025 earnings released: EPS: JP¥139 (vs JP¥119 in 3Q 2024)Third quarter 2025 results: EPS: JP¥139 (up from JP¥119 in 3Q 2024). Revenue: JP¥10.9b (down 7.5% from 3Q 2024). Net income: JP¥1.15b (up 17% from 3Q 2024). Profit margin: 11% (up from 8.4% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 28% per year whereas the company’s share price has increased by 24% per year.
分析記事 • Dec 11Soken Chemical & Engineering (TSE:4972) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Reported Earnings • Nov 08Second quarter 2025 earnings released: EPS: JP¥163 (vs JP¥99.81 in 2Q 2024)Second quarter 2025 results: EPS: JP¥163 (up from JP¥99.81 in 2Q 2024). Revenue: JP¥12.7b (up 24% from 2Q 2024). Net income: JP¥1.35b (up 63% from 2Q 2024). Profit margin: 11% (up from 8.1% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 20% per year.
Board Change • Nov 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Outside Director Takayoshi Fusegi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.3% average weekly change).
Buy Or Sell Opportunity • Sep 17Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to JP¥3,230. The fair value is estimated to be JP¥2,669, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
分析記事 • Sep 01Soken Chemical & Engineering Co., Ltd. (TSE:4972) Soars 29% But It's A Story Of Risk Vs RewardSoken Chemical & Engineering Co., Ltd. ( TSE:4972 ) shares have had a really impressive month, gaining 29% after a...
Reported Earnings • Aug 07First quarter 2025 earnings released: EPS: JP¥176 (vs JP¥66.30 in 1Q 2024)First quarter 2025 results: EPS: JP¥176 (up from JP¥66.30 in 1Q 2024). Revenue: JP¥11.7b (up 29% from 1Q 2024). Net income: JP¥1.46b (up 166% from 1Q 2024). Profit margin: 13% (up from 6.1% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 7% per year, which means it is tracking significantly ahead of earnings growth.
Buy Or Sell Opportunity • Aug 06Now 22% overvaluedOver the last 90 days, the stock has fallen 13% to JP¥2,600. The fair value is estimated to be JP¥2,136, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has declined by 12%. For the next 3 years, revenue is forecast to grow by 8.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.9% average weekly change).
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to JP¥2,100, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 13% over the past three years.
Reported Earnings • May 21Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: JP¥318 (up from JP¥174 in FY 2023). Revenue: JP¥41.3b (up 8.4% from FY 2023). Net income: JP¥2.63b (up 83% from FY 2023). Profit margin: 6.4% (up from 3.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 6.0%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
お知らせ • May 17Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 26, 2024Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 26, 2024.
New Risk • Apr 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.7% average weekly change).
Upcoming Dividend • Mar 21Upcoming dividend of JP¥95.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 26 June 2024. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).
お知らせ • Mar 02+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q1, 2025 Results on Aug 05, 2024Soken Chemical & Engineering Co., Ltd. announced that they will report Q1, 2025 results on Aug 05, 2024
Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: JP¥119 (vs JP¥7.50 in 3Q 2023)Third quarter 2024 results: EPS: JP¥119 (up from JP¥7.50 in 3Q 2023). Revenue: JP¥11.8b (up 22% from 3Q 2023). Net income: JP¥988.0m (up JP¥926.0m from 3Q 2023). Profit margin: 8.4% (up from 0.6% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • Jan 24Now 20% undervaluedOver the last 90 days, the stock has risen 46% to JP¥2,688. The fair value is estimated to be JP¥3,368, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has declined by 21%. Revenue is forecast to grow by 29% in 2 years. Earnings are forecast to grow by 91% in the next 2 years.
New Risk • Nov 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.4% average weekly change).
Reported Earnings • Nov 07Second quarter 2024 earnings released: EPS: JP¥99.80 (vs JP¥29.54 in 2Q 2023)Second quarter 2024 results: EPS: JP¥99.80 (up from JP¥29.54 in 2Q 2023). Revenue: JP¥10.2b (up 12% from 2Q 2023). Net income: JP¥826.0m (up 238% from 2Q 2023). Profit margin: 8.1% (up from 2.7% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥2,105, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 70% over the past three years.
New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.4b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.1% net profit margin). Market cap is less than US$100m (JP¥14.4b market cap, or US$99.1m).
New Risk • Aug 09New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 5.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.1% net profit margin).
Reported Earnings • Aug 09First quarter 2024 earnings released: EPS: JP¥66.29 (vs JP¥101 in 1Q 2023)First quarter 2024 results: EPS: JP¥66.29 (down from JP¥101 in 1Q 2023). Revenue: JP¥9.05b (down 13% from 1Q 2023). Net income: JP¥548.0m (down 34% from 1Q 2023). Profit margin: 6.1% (down from 8.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Reported Earnings • May 19Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: JP¥174 (down from JP¥247 in FY 2022). Revenue: JP¥38.1b (down 1.3% from FY 2022). Net income: JP¥1.44b (down 30% from FY 2022). Profit margin: 3.8% (down from 5.3% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 11%. Revenue is forecast to grow 9.4% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥85.00 per share at 4.8% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 27 June 2023. Payout ratio is a comfortable 41% but the company is not cash flow positive. Trailing yield: 4.8%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).
Reported Earnings • Feb 04Third quarter 2023 earnings released: EPS: JP¥7.50 (vs JP¥61.32 in 3Q 2022)Third quarter 2023 results: EPS: JP¥7.50 (down from JP¥61.32 in 3Q 2022). Revenue: JP¥9.64b (down 4.8% from 3Q 2022). Net income: JP¥62.0m (down 88% from 3Q 2022). Profit margin: 0.6% (down from 5.0% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 9% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Nov 16No independent directorsThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 8 new directors. 3 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). President & Director Junichiro Fukuda is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Nov 06Second quarter 2023 earnings released: EPS: JP¥29.54 (vs JP¥59.67 in 2Q 2022)Second quarter 2023 results: EPS: JP¥29.54 (down from JP¥59.67 in 2Q 2022). Revenue: JP¥9.08b (flat on 2Q 2022). Net income: JP¥244.0m (down 50% from 2Q 2022). Profit margin: 2.7% (down from 5.5% in 2Q 2022). Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 13% per year.
Reported Earnings • Aug 07First quarter 2023 earnings released: EPS: JP¥101 (vs JP¥83.42 in 1Q 2022)First quarter 2023 results: EPS: JP¥101 (up from JP¥83.42 in 1Q 2022). Revenue: JP¥10.4b (up 19% from 1Q 2022). Net income: JP¥836.0m (up 22% from 1Q 2022). Profit margin: 8.1% (up from 7.9% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.0%, compared to a 9.5% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 17Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: JP¥247 (down from JP¥331 in FY 2021). Revenue: JP¥38.6b (up 23% from FY 2021). Net income: JP¥2.04b (down 25% from FY 2021). Profit margin: 5.3% (down from 8.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 36%. Over the next year, revenue is forecast to stay flat compared to a 7.7% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
お知らせ • May 15Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2022Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 24, 2022.
Board Change • Apr 27No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 8 non-independent directors. Full-Time Auditor Nobuyuki Izumiura was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.
お知らせ • Apr 08+ 3 more updatesSoken Chemical & Engineering Co., Ltd. to Report Q2, 2023 Results on Nov 04, 2022Soken Chemical & Engineering Co., Ltd. announced that they will report Q2, 2023 results on Nov 04, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥75.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (2.6%).
Reported Earnings • Feb 07Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: JP¥61.31 (down from JP¥104 in 3Q 2021). Revenue: JP¥10.1b (up 21% from 3Q 2021). Net income: JP¥506.0m (down 41% from 3Q 2021). Profit margin: 5.0% (down from 10% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) also surpassed analyst estimates by 13%. Over the next year, revenue is forecast to grow 4.2%, compared to a 6.8% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 07Second quarter 2022 earnings released: EPS JP¥59.66 (vs JP¥83.13 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: JP¥9.02b (up 25% from 2Q 2021). Net income: JP¥492.0m (down 28% from 2Q 2021). Profit margin: 5.5% (down from 9.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 07Second quarter 2022 earnings released: EPS JP¥59.66 (vs JP¥83.13 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: JP¥9.02b (up 25% from 2Q 2021). Net income: JP¥492.0m (down 28% from 2Q 2021). Profit margin: 5.5% (down from 9.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 29Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥1,770, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 11x in the Chemicals industry in Japan. Total returns to shareholders of 14% over the past three years.
Reported Earnings • Aug 05First quarter 2022 earnings released: EPS JP¥83.41 (vs JP¥61.83 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥8.72b (up 28% from 1Q 2021). Net income: JP¥687.0m (up 35% from 1Q 2021). Profit margin: 7.9% (up from 7.5% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 17Full year 2021 earnings released: EPS JP¥331 (vs JP¥198 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥31.5b (up 9.7% from FY 2020). Net income: JP¥2.72b (up 67% from FY 2020). Profit margin: 8.6% (up from 5.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
分析記事 • May 02Soken Chemical & Engineering (TYO:4972) Is Doing The Right Things To Multiply Its Share PriceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Upcoming Dividend • Mar 23Upcoming dividend of JP¥75.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 26 June 2021. Trailing yield: 3.3%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.8%).
分析記事 • Mar 11These 4 Measures Indicate That Soken Chemical & Engineering (TYO:4972) Is Using Debt SafelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Feb 21Should You Think About Buying Soken Chemical & Engineering Co., Ltd. (TYO:4972) Now?While Soken Chemical & Engineering Co., Ltd. ( TYO:4972 ) might not be the most widely known stock at the moment, it...
Is New 90 Day High Low • Feb 08New 90-day high: JP¥2,545The company is up 55% from its price of JP¥1,643 on 10 November 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
Reported Earnings • Feb 07Third quarter 2021 earnings released: EPS JP¥104 (vs JP¥71.81 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥8.38b (up 17% from 3Q 2020). Net income: JP¥860.0m (up 46% from 3Q 2020). Profit margin: 10% (up from 8.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Analyst Estimate Surprise Post Earnings • Feb 07Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 2.8%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Over the next year, revenue is forecast to grow 5.3%, compared to a 6.2% growth forecast for the Chemicals industry in Japan.
分析記事 • Feb 02Why Dividend Hunters Love Soken Chemical & Engineering Co., Ltd. (TYO:4972)Dividend paying stocks like Soken Chemical & Engineering Co., Ltd. ( TYO:4972 ) tend to be popular with investors, and...
分析記事 • Jan 15What Do The Returns At Soken Chemical & Engineering (TYO:4972) Mean Going Forward?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Is New 90 Day High Low • Jan 13New 90-day high: JP¥2,120The company is up 39% from its price of JP¥1,526 on 15 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period.
Is New 90 Day High Low • Dec 29New 90-day high: JP¥1,931The company is up 29% from its price of JP¥1,499 on 30 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
分析記事 • Dec 28Did You Participate In Any Of Soken Chemical & Engineering's (TYO:4972) Fantastic 117% Return ?Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
分析記事 • Dec 10We Think Soken Chemical & Engineering (TYO:4972) Can Manage Its Debt With EaseThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Is New 90 Day High Low • Dec 08New 90-day high: JP¥1,919The company is up 39% from its price of JP¥1,383 on 09 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
分析記事 • Nov 22Is Soken Chemical & Engineering Co., Ltd. (TYO:4972) Potentially Undervalued?While Soken Chemical & Engineering Co., Ltd. (TYO:4972) might not be the most widely known stock at the moment, it saw...
Reported Earnings • Nov 07Second quarter 2021 earnings released: EPS JP¥83.13The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: JP¥7.21b (down 1.2% from 2Q 2020). Net income: JP¥684.0m (up 50% from 2Q 2020). Profit margin: 9.5% (up from 6.2% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 8% per year.
Analyst Estimate Surprise Post Earnings • Nov 07Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Over the next year, revenue is forecast to stay flat compared to a 2.0% growth forecast for the Chemicals industry in Japan.
Is New 90 Day High Low • Nov 06New 90-day high: JP¥1,770The company is up 38% from its price of JP¥1,286 on 07 August 2020. The Japanese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Nov 06Market bids up stock over the past weekAfter last week's 26% share price gain to JP¥1,770, the stock is trading at a trailing P/E ratio of 7.7x, up from the previous P/E ratio of 6.1x. This compares to an average P/E of 14x in the Chemicals industry in Japan. Total return to shareholders over the past three years is a loss of 11%.
Is New 90 Day High Low • Oct 05New 90-day high: JP¥1,516The company is up 25% from its price of JP¥1,209 on 07 July 2020. The Japanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.